Mucoadhesive oral films: The potential for unmet needs

International Journal of Pharmaceutics
Branca M A SilvaSérgio Simões

Abstract

Oral drug delivery is the most common route of drug administration. Nevertheless, there are some important limitations that reinforce the need for developing new drug delivery systems. Mucoadhesive oral films (MOF) are promising dosage forms that adhere to the oral mucosa and deliver the drug through it, which present several advantages. These include: bypassing the hepatic first pass effect, fast onset of action, ease of transportation and handling. The use of such dosage form is beneficial for drugs that have poor oral bioavailability and also for drugs that need to be rapidly absorbed. In spite of the known benefits, the number of marketed MOF is still quite small. This review explores the products under development and corresponding clinical trials in respect to their status, therapeutic indication, companies involved and technologies. In this way, it was possible to identify the preferred therapeutic indications, new research and market trends as well as future prospects of MOF. Moreover, it is reasonable to expect an increase in the number of products on the market due to their great potential to satisfy unmet medical needs.

References

May 26, 2004·International Journal of Pharmaceutics·G IkinciM Sumnu
May 25, 2006·Nature Methods·Andrew Sharp
Dec 11, 2007·Nature Biotechnology·George S Mack
May 22, 2008·Expert Opinion on Drug Delivery·S Indiran PatherSevda Senel
Nov 6, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Gavin P AndrewsDavid S Jones
Jun 30, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·R P Dixit, S P Puthli
Aug 12, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·N V Satheesh MadhavKuldeep Singh
Jan 29, 2010·Diabetes Care·UNKNOWN American Diabetes Association
Mar 12, 2010·Expert Review of Vaccines·Tamar Ben-Yedidia
Nov 10, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Pragati ShakyaKuldeep Singh
Dec 7, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Javier O Morales, Jason T McConville
Feb 3, 2011·Expert Opinion on Drug Delivery·Eva Maria HoffmannJörg Breitkreutz
Feb 9, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Viralkumar F PatelMarc B Brown
Mar 30, 2011·Allergy·S RadulovicStephen Durham
Mar 28, 2012·Methods in Enzymology·Catarina Pinto Reis, Christiane Damgé
Apr 20, 2012·Expert Opinion on Drug Delivery·Sevda ŞenelIndiran Pather
Oct 27, 2012·Expert Opinion on Drug Delivery·Sandra SoaresBruno Sarmento
Dec 12, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Anroop B NairIbrahim A Alhaider
Jun 19, 2013·Expert Opinion on Drug Delivery·Maren PreisJörg Breitkreutz
Jul 16, 2013·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Christina WoertzPeter Kleinebudde
Mar 1, 2014·Annals of the American Thoracic Society·Neal L Benowitz
Mar 1, 2014·Drug Development and Industrial Pharmacy·Flavia Laffleur
Mar 26, 2014·BMJ : British Medical Journal·Todd J Schwedt
Apr 9, 2014·Expert Opinion on Investigational Drugs·Jamee Castillo, Vesselin Dimov
Apr 25, 2014·Current Pain and Headache Reports·Andrew N Davies
May 21, 2014·Current Medical Research and Opinion·Gerhard Müller-SchwefePatrick Sichère
Jun 1, 2014·International Journal of Pharmaceutics·Mohammed SattarMajella E Lane
Jun 10, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Heleen KraanJean-Pierre Amorij
Jun 29, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ebbe Juel Bech NielsenMariko Takeda-Morishita
Aug 5, 2014·International Journal of Pharmaceutics·Tatiana AndreaniEliana B Souto
Nov 30, 2014·Neuropharmacology·K J JacksonM I Damaj
Feb 17, 2015·International Journal of Pharmaceutics·Maren PreisNiklas Sandler
Mar 10, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ana Filipa BorgesSérgio Simões
Mar 18, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ana Filipa BorgesSérgio Simões

❮ Previous
Next ❯

Citations

Apr 17, 2016·AAPS PharmSciTech·Miguel Montenegro-Nicolini, Javier O Morales
Jun 14, 2016·Pharmaceutical Development and Technology·Veronika WalicováDavid Vetchý
Oct 16, 2016·The AAPS Journal·Miguel Montenegro-NicoliniJavier O Morales
Jun 21, 2017·International Journal of Pharmaceutics·Branca M A SilvaSérgio Simões
Nov 8, 2017·Progress in Biomaterials·Sahar Salehi, Soheil Boddohi
Dec 12, 2018·Advanced Healthcare Materials·Rachel L Creighton, Kim A Woodrow
Jan 4, 2017·Expert Opinion on Drug Delivery·Sandra Lindert, Jörg Breitkreutz
Jul 3, 2019·Therapeutic Delivery·Bartholomew Yir-ErongJoshua S Boateng
Jun 16, 2016·AAPS PharmSciTech·Soledad Montero-PadillaJavier O Morales
Nov 30, 2018·The Journal of Pharmacy and Pharmacology·Ajinkya M BhagurkarMichael A Repka
Sep 17, 2019·Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences·Fahimeh PakravanPegah Noorshargh
Jan 25, 2021·International Journal of Pharmaceutics·M ElbadawiA W Basit
Mar 2, 2021·International Journal of Pharmaceutics·Maria Francesca Di FilippoSilvia Panzavolta
May 26, 2021·Drug Development and Industrial Pharmacy·Ana Paula de Sá Pinto Abrahão MagalhãesClaudia Regina Elias Mansur

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Advanced Drug Delivery Reviews
Jenny K W LamIan C K Wong
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Javier O Morales, Jason T McConville
Drug Development and Industrial Pharmacy
Flavia Laffleur
Journal of Diabetes Science and Technology
Pedro FonteBruno Sarmento
© 2021 Meta ULC. All rights reserved